Literature DB >> 10431838

PACSIN 2, a novel member of the PACSIN family of cytoplasmic adapter proteins.

B Ritter1, J Modregger, M Paulsson, M Plomann.   

Abstract

The PACSIN-related proteins are cytoplasmic adapter proteins with a common arrangement of domains and conserved regions. Here we report the cloning, sequencing, and expression of PACSIN 2, a novel member of the PACSIN protein family and accordingly rename the original PACSIN to PACSIN 1. The sequences of the murine and human cDNAs reveal an open reading frame encoding a putative protein of 486 residues. Despite its high sequence similarity to PACSIN 1, PACSIN 2 is encoded by distinct transcripts in human and mouse, in particular displaying a ubiquitous expression pattern. Immunofluorescence microscopy of PACSIN 2-transfected NIH3T3 fibroblasts reveal a broad, vesicle-like cytoplasmic staining. In contrast to FAP52, another PACSIN-related protein derived from chicken brain, PACSIN 2 could not be detected at focal contacts. Taken together, these findings suggest that PACSIN 2 is a novel PACSIN isoform with similar domain and motif arrangement, but an unrestricted expression pattern, which may participate in the organization of the actin cytoskeleton and the regulation of vesicular traffic.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431838     DOI: 10.1016/s0014-5793(99)00830-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Cloning, purification, crystallization and preliminary X-ray diffraction analysis of mouse PACSIN 3 protein.

Authors:  Xiaoyun Bai; Geng Meng; Xiaofeng Zheng
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-01-25

2.  The cytoplasmic protein Pacsin 2 in kidney development and injury repair.

Authors:  Gang Yao; Annouck Luyten; Ayumi Takakura; Markus Plomann; Jing Zhou
Journal:  Kidney Int       Date:  2012-12-12       Impact factor: 10.612

Review 3.  The Rac1 hypervariable region in targeting and signaling: a tail of many stories.

Authors:  B Daniel Lam; Peter L Hordijk
Journal:  Small GTPases       Date:  2013-01-25

4.  Syndapin 3 modulates fusion pore expansion in mouse neuroendocrine chromaffin cells.

Authors:  Prattana Samasilp; Kyle Lopin; Shyue-An Chan; Rajesh Ramachandran; Corey Smith
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-05       Impact factor: 4.249

5.  PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b.

Authors:  Hui Meng; Lifeng Tian; Jie Zhou; Zhiping Li; Xuanmao Jiao; Wayne W Li; Markus Plomann; Zhishun Xu; Michael P Lisanti; Chenguang Wang; Richard G Pestell
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

6.  Polycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex.

Authors:  Gang Yao; Xuefeng Su; Vy Nguyen; Kristina Roberts; Xiaogang Li; Ayumi Takakura; Markus Plomann; Jing Zhou
Journal:  Hum Mol Genet       Date:  2014-01-02       Impact factor: 6.150

7.  Tip-to-tip interaction in the crystal packing of PACSIN 2 is important in regulating tubulation activity.

Authors:  Xiaoyun Bai; Xiaofeng Zheng
Journal:  Protein Cell       Date:  2013-07-26       Impact factor: 14.870

8.  Analysis of substrates of protein kinase C isoforms in human breast cells by the traceable kinase method.

Authors:  Xiangyu Chen; Xin Zhao; Thushara P Abeyweera; Susan A Rotenberg
Journal:  Biochemistry       Date:  2012-08-29       Impact factor: 3.162

9.  FlnA binding to PACSIN2 F-BAR domain regulates membrane tubulation in megakaryocytes and platelets.

Authors:  Antonija Jurak Begonja; Fred G Pluthero; Worawit Suphamungmee; Silvia Giannini; Hilary Christensen; Richard Leung; Richard W Lo; Fumihiko Nakamura; William Lehman; Markus Plomann; Karin M Hoffmeister; Walter H A Kahr; John H Hartwig; Hervé Falet
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

Review 10.  Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.

Authors:  Sanja Sever; Mario Schiffer
Journal:  Kidney Int       Date:  2018-04-17       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.